These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Changing Disparity of Gastric Cancer Incidence by Histological Types in US Race-Specific Populations. Zhu X; Pigazzi A; Zell J; Lu Y Cancer Control; 2020; 27(1):1073274820977152. PubMed ID: 33297759 [TBL] [Abstract][Full Text] [Related]
8. [Clinicopathological features and prognosis of different gastric carcinoid subtypes]. Liang JW; Zhou ZX; Liu Q; Bai XF; Zhao P Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):866-9. PubMed ID: 19173835 [TBL] [Abstract][Full Text] [Related]
9. Gastric carcinoids: a temporal increase with proton pump introduction. Hodgson N; Koniaris LG; Livingstone AS; Franceschi D Surg Endosc; 2005 Dec; 19(12):1610-2. PubMed ID: 16211437 [TBL] [Abstract][Full Text] [Related]
10. A population-based study of the incidence of malignant small bowel tumours: SEER, 1973-1990. Chow JS; Chen CC; Ahsan H; Neugut AI Int J Epidemiol; 1996 Aug; 25(4):722-8. PubMed ID: 8921448 [TBL] [Abstract][Full Text] [Related]
12. Gastric carcinoids: a statistical evaluation of 1,094 cases collected from the literature. Soga J Surg Today; 1997; 27(10):892-901. PubMed ID: 10870573 [TBL] [Abstract][Full Text] [Related]
13. Carcinoids and high-grade neuroendocrine carcinomas of the ampulla of vater: a comparative analysis of 139 cases from the surveillance, epidemiology, and end results program-a population based study. Albores-Saavedra J; Hart A; Chablé-Montero F; Henson DE Arch Pathol Lab Med; 2010 Nov; 134(11):1692-6. PubMed ID: 21043824 [TBL] [Abstract][Full Text] [Related]
14. 20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes: Milano AF J Insur Med; 2019; 48(1):5-23. PubMed ID: 31609640 [No Abstract] [Full Text] [Related]
15. A 35-year retrospective study of carcinoid tumors in Taiwan: differences in distribution with a high probability of associated second primary malignancies. Li AF; Hsu CY; Li A; Tai LC; Liang WY; Li WY; Tsay SH; Chen JY Cancer; 2008 Jan; 112(2):274-83. PubMed ID: 18008361 [TBL] [Abstract][Full Text] [Related]
16. Malignant carcinoids in the USA, SEER 1992-1999. An epidemiological study with 6830 cases. Crocetti E; Paci E Eur J Cancer Prev; 2003 Jun; 12(3):191-4. PubMed ID: 12771556 [TBL] [Abstract][Full Text] [Related]
17. Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type. Borch K; Ahrén B; Ahlman H; Falkmer S; Granérus G; Grimelius L Ann Surg; 2005 Jul; 242(1):64-73. PubMed ID: 15973103 [TBL] [Abstract][Full Text] [Related]
18. Hypergastrinemia and recurrent type 1 gastric carcinoid in a young Indian male: necessity for antrectomy? Senadhi V; Jani N World J Gastroenterol; 2011 Sep; 17(35):4052-4. PubMed ID: 22046097 [TBL] [Abstract][Full Text] [Related]
19. Risk of second cancers in patients with colorectal carcinoids. Tichansky DS; Cagir B; Borrazzo E; Topham A; Palazzo J; Weaver EJ; Lange A; Fry RD Dis Colon Rectum; 2002 Jan; 45(1):91-7. PubMed ID: 11786770 [TBL] [Abstract][Full Text] [Related]
20. Increasing incidence of adenocarcinomas and carcinoid tumors of the small intestine in adults. Severson RK; Schenk M; Gurney JG; Weiss LK; Demers RY Cancer Epidemiol Biomarkers Prev; 1996 Feb; 5(2):81-4. PubMed ID: 8850266 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]